Aspire Biopharma Holdings, Inc. (ASBP)

NASDAQ: ASBP · USD

$8.86

+0.42 (+5.0%)· Recorded snapshot

Market cap	12.4M
Revenue (ttm)	97.7K
Net income (ttm)	-11M
EPS (ttm)	-$33.3
Shares out	1.4M
Volume	13,442
Beta	0.17

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 97.7K
Net income (ttm): -11M
EPS (ttm): -$33.3
Market cap: 12.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ABNB	Airbnb, Inc.	97.8B	37.5x	7.4x	16.8%	+24.4%	+28.5%	Sprzedaj
AMZN	Amazon.com Inc.	2.7T	20.5x	3.5x	11.9%	+11.8%	+12.2%	Sprzedaj
APTV	Aptiv PLC	9.1B	42.8x	0.4x	7.8%	+5.5%	-49.2%	Kupuj

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-1,032.1

P25 n/aP50 n/aP75 n/a

ROIC82.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ASBP indicators

Market & fundamental data

Available fields

176

Groups with data

Currency

USD

Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001847345
Company name	Aspire Biopharma Holdings, Inc.
Country	United States
Country code	US
CUSIP number	738920305
Earnings date	2026-11-13
Earnings time	bmo
Enterprise value	$259,519
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2021
Industry	Auto Parts
Is primary listing	Yes
Is SPAC	No
ISIN number	US7389203057
Last 10-K release date	2026-03-30
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split date	2026-05-11
Last stock split type	Reverse
Market cap	$12.4M
Market cap category	Nano-Cap
Next earnings date	2026-11-13
Options	No
Price	$8.86
Price currency	USD
Sector	Consumer Discretionary
SIC code	2834
Stock price date	2026-10-28
Symbol	ASBP
U.S. state	Florida
Website	https://aspirelakewoodholdings.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-376.22%
FCF / EV yield	2,180.47%
FCF yield	-60.7%
Industry forward P/E	15.95x
Industry P/E	74.94x
P/B ratio	0.93x
P/S ratio	121.21x
Price / tangible book value	1.01x
Sector forward P/E	24.39x
Sector P/E	30.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	7,210.15%
Gross margin	-25.04%
Operating margin	7,210.15%
Pretax margin	-11,314.12%
ROA	60.58%
ROCE	59.4%
ROE	-1,032.14%
ROIC	82.92%
SBC / revenue	161.28%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	3
EPS growth years	0
Net income growth quarters	2
Net income growth years	0
Revenue growth (QoQ)	122.57%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
EBIT	$7M
EPS	$-33.33
FCF per share	$-5.12
Financing cash flow	$19.1M
Free cash flow	$-7.2M
Free cash flow minus SBC	$-7.3M
Gross profit	$-24,452
Net borrowing	$2.2M
Net cash flow	$12M
Net income	$-11M
Operating cash flow minus SBC	$-7.3M
Operating income	$7M
Revenue	$97,659
Stock-based compensation	$157,500

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.31
Book value per share	$9.08
Debt / equity	0
Interest coverage	0.76
Long-term assets	$75,000
Long-term liabilities	$96,527
Net cash (debt)	$12.2M
Net cash / market cap	102.78%
Net debt / equity	-1.03
Piotroski F-Score	3
Shareholders' equity	$11.8M
Tangible book value	$11.8M
Tangible book value per share	$9.08
Total assets	$13.5M
Total cash	$12.2M
Total debt	$0
Total liabilities	$1.8M
WACC	5.2%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.01
Current assets	$13.5M
Current liabilities	$1.7M
Current ratio	7.99
Net working capital	$-387,788
Quick ratio	7.22
Working capital	$11.8M
Working capital turnover	0.09

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1,015.92%
Dividend yield	0%
Shareholder yield	-1,015.92%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$9.36
1D price change	4.98%
1M price change	5.89%
1M total return	5.89%
1W price change	1.03%
1W total return	1.03%
1Y price change	-97.89%
1Y return CAGR	-97.89%
1Y total return	-97.89%
20-day SMA	$8.52
200-day SMA	$17.95
3M price change	26.4%
3M total return	26.4%
3Y price change	-99.93%
3Y return CAGR	-91.22%
3Y total return	-99.93%
50-day SMA	$8.54
50-day SMA vs 200-day SMA	50under200
52-week high	$562.92
52-week high date	2025-10-30
52-week low	$3.31
52-week low date	2026-05-08
6M price change	19.86%
6M total return	19.86%
All-time high	$18,960.02
All-time high date	2025-02-12
All-time low	$3.31
All-time low date	2026-05-08
Average true range (ATR)	$0.61
Average volume	30.7K
Beta (1Y)	-0.44
Beta (2Y)	1.81
Beta (5Y)	0.17
Change from 52-week high	-98.43%
Change from 52-week low	167.76%
Change from all-time high	-99.95%
Change from all-time low	166.24%
Change from open	0%
Day's gap	4.98%
Dollar volume	$119,096
High price	$8.86
Low price	$8.86
Monthly RSI	18.38
Open price	$8.86
Premarket change	-3.08%
Premarket close	$8.44
Premarket price	$8.18
Previous close	$8.44
Price vs 150-day SMA	-5.84%
Price vs 20-day SMA	3.4%
Price vs 200-day SMA	-50.91%
Price vs 50-day SMA	3.22%
Relative volume	0.44
RSI	54.06
Sharpe ratio	-1.32
Sharpe ratio (3Y)	-0.55
Sortino ratio	-1.73
Sortino ratio (3Y)	-0.94
Volume	13.4K
Weekly RSI	24.51
YTD price change	-94.43%
YTD total return	-94.43%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.1M
Float percentage	79.72%
Shares change (QoQ)	562.4%
Shares change (YoY)	1,015.92%
Shares held by insiders	20.11%
Shares held by institutions	5.41%
Shares outstanding	1.4M
Short % of float	1.22%
Short % of shares	0.97%
Short ratio	0.4 days

Deeper analysis on ASBP

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASBP report

Is a complete ASBP research report available?

No complete published report is available for Aspire Biopharma Holdings, Inc. (ASBP) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Aspire Biopharma Holdings, Inc. (ASBP)

Price

Financial snapshot

Fair-value bridge

Latest news · ASBP

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASBP indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASBP

Frequently asked questions